Practical issues drawn from the implementation of the integrated test for Down syndrome screening into routine clinical practice.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 17309546.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
We have evaluated a cohort of women booked for antenatal care at University College London Hospitals. The uptake of screening was 64.4% and was significantly higher (73 versus 46%) in women who booked before 14 weeks. Of the women who booked before 14 weeks, 96.8% opted for the integrated test (IT). Overall, 5.3% failed to attend for the second blood test. The false-positive rate in the women who had the IT was 2.9%. All 11 cases of Down syndrome were detected prenatally. Our study is the first to evaluate implementation of the IT into routine clinical practice.
Medical subject headings
- Down Syndrome
- Mass Screening
- Prenatal Diagnosis